Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Intraday Session

Author: Benzinga Insights | April 26, 2023 01:31pm

Gainers

  • EUDA Health Holdings (NASDAQ:EUDA) shares rose 45.3% to $2.14 during Wednesday's regular session. As of 13:30 EST, EUDA Health Holdings's stock is trading at a volume of 13.1 million, which is 1251.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $47.7 million.
  • Etao International Co (NASDAQ:ETAO) shares rose 34.66% to $1.01. Trading volume for this security as of 13:30 EST is 9.9 million, which is 1358.4% of its average full-day volume over the last 100 days. The company's market cap stands at $103.3 million.
  • Cryo-Cell International (AMEX:CCEL) stock rose 28.67% to $5.34. The market value of their outstanding shares is at $44.3 million. The company's, Q1 earnings came out 3 days ago.
  • Vaxxinity (NASDAQ:VAXX) shares rose 20.8% to $2.09. The current volume of 297.6K shares is 135.0% of Vaxxinity's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $263.4 million.
  • Cytek Biosciences (NASDAQ:CTKB) stock rose 14.62% to $10.97. The current volume of 1.8 million shares is 274.5% of Cytek Biosciences's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $1.4 billion.
  • Minerva Neurosciences (NASDAQ:NERV) shares moved upwards by 14.15% to $2.66. The market value of their outstanding shares is at $14.2 million.

Losers

  • ZyVersa Therapeutics (NASDAQ:ZVSA) shares fell 70.6% to $0.47 during Wednesday's regular session. The current volume of 11.0 million shares is 2938.6% of ZyVersa Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $4.3 million.
  • Baudax Bio (NASDAQ:BXRX) stock decreased by 27.76% to $1.51. As of 13:30 EST, this security is trading at a volume of 1.8 million shares, making up 161.5% of its average full-day volume over the last 100 days. The company's market cap stands at $3.9 million.
  • Evelo Biosciences (NASDAQ:EVLO) shares decreased by 27.39% to $0.11. Trading volume for this security as of 13:30 EST is 1.9 million, which is 588.4% of its average full-day volume over the last 100 days. The company's market cap stands at $12.0 million.
  • Apollomics (NASDAQ:APLM) shares fell 26.36% to $4.75. Trading volume for this security as of 13:30 EST is 335.3K, which is 119.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $412.2 million.
  • GRI Bio (NASDAQ:GRI) stock decreased by 24.79% to $6.1. As of 13:30 EST, GRI Bio's stock is trading at a volume of 58.6K, which is 31.7% of its average full-day volume over the last 100 days.
  • TRACON Pharma (NASDAQ:TCON) stock fell 24.74% to $0.71. As of 13:30 EST, this security is trading at a volume of 1.0 million shares, making up 710.7% of its average full-day volume over the last 100 days. The company's market cap stands at $17.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: APLM BXRX CCEL CTKB ETAO EUDA EVLO GRI NERV TCON VAXX ZVSA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist